ALDH1A3 and neoplasm: Here, we terminated the experiment on day 49 for the MDA-MB-231 tumors, noting a significant increase in tumor volume upon ALDH1A3 OE (Figure 2A), and day 74 for the slower-growing MDA-MB-436 tumors (Figure 2B).